Kestrel Therapeutics

0 followers


Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patien... Read more

Employees

11-50

Links


Org chart

Frank Haluska
President And CEO
Collapse
Mark Bilodeau
Chief Scientific Officer
Ross Pettit
Chief Development Officer
Omar A.
Vice President
Shyam Karki
Vice President And Head Of CMC
Ashwin Gollerkeri
Chief Medical Officer